Table 1.

Baseline features of patients in the IgAN triala

Prednisone GroupO3FA GroupPlacebo GroupP
Age (yr)24 ± 1020 ± 1021 ± 100.19
White (%)5972840.07
Male (%)7066650.90
Hypertensive (%)5553480.88
Systolic BP127 ± 12127 ± 15124 ± 160.41
Diastolic BP79 ± 1475 ± 1378 ± 110.35
eGFR (ml/min per 1.73 m2)109 ± 39117 ± 43118 ± 470.68
UP/C ratio2.2 ± 2.52.1 ± 1.31.4 ± 1.20.02
  • a Data are mean ± 1 SD except where indicated. eGFR, estimated GFR; IgAN, IgA nephropathy; O3FA, omega 3 fatty acids; UP/C, urinary protein/creatinine.